① Recently, CRRC Corporation signed new contracts worth approximately 55 billion yuan. How significant is the impact on performance? ② SUNNY OPTICAL's onboard camera shipments increased by nearly 30% in April. How is the performance of the smartphone camera business?
The important announcements for Hong Kong Stocks today are as follows:
1) Company News
$CKH HOLDINGS (00001.HK)$ A statement was released in response to the port trade: it is absolutely impossible to conduct any transactions in an illegal or non-compliant manner.
CKH HOLDINGS announced that it originally planned to discuss the port trade at the shareholder annual meeting on May 22, but in light of the recent continuous inquiries from shareholders and the media, the group makes the following response: CKH Holdings Limited hereby states that this transaction is absolutely impossible to be conducted in any illegal or non-compliant manner. The relevant provisions have been outlined in the announcement dated March 4, 2025: "The completion of the transaction depends on the fulfillment of a series of conditions, including approvals and consent from legal and regulatory authorities, absence of illegal or legally prohibited situations, obtaining necessary approvals from company shareholders, and other appropriate and usual conditions stipulated in the final documents."
$CRRC Corporation (601766.SH)$The company and its subsidiaries recently signed several major contracts, involving approximately 54.74 billion yuan, accounting for about 22.2% of the company's revenue in 2024.
$SUNNY OPTICAL (02382.HK)$ In April, the shipment volume of mobile phone lenses reached 0.103 billion units, an increase of 9.2% month-on-month and 1.3% year-on-year; the shipment volume of Onboard Cameras was 11.566 million units, an increase of 17.8% month-on-month and 28.9% year-on-year. This was primarily due to increased customer demand and improvements in product structure.
$REMEGEN (09995.HK)$ The National Medical Products Administration approved the injection of Vadisigmat for the treatment of HER2-positive advanced breast cancer with liver metastasis to be marketed in China.
REMEGEN announced that the injection of Vadisigmat (brand name: Aidiqi) has formally obtained approval from the National Medical Products Administration (NMPA) to be marketed in China for patients with HER2-positive advanced breast cancer with liver metastasis.
$POU SHENG INT'L (03813.HK)$In the first quarter, revenue was approximately 5.107 billion yuan, a decrease of 5.4% year-on-year; Net income was approximately 0.138 billion yuan, a decrease of 20.65% year-on-year. In the first four months, the cumulative comprehensive net operating income was approximately 6.481 billion yuan, a year-on-year decline of 7.7%.
$YUE YUEN IND (00551.HK)$In the first quarter, revenue was approximately 2.0295 billion dollars, a year-on-year increase of 1.3%; net income was 75.758 million dollars, a decrease of 24.2% year-on-year. The cumulative net operating income for the first four months was 2.687 billion dollars, an increase of 1.3% compared to the previous year.
$CITIC (00267.HK)$POU SHENG INT'L's wholly-owned subsidiary Jin'an Mining won the bidding to obtain the exploration rights for the Fanqiao Iron Mine, involving an investment of 0.92 billion yuan.
$YANKUANG ENERGY (01171.HK)$Qinghai Salt Lake plans to subscribe for shares of Highland Resources for approximately 0.3 billion dollars in cash and become its largest shareholder.
$POWERLONG (01238.HK)$The hearing for the liquidation application has been rescheduled to July 21.
$UBOX ONLINE (02429.HK)$: Completed full circulation of H shares.
2) Buyback dynamics.
$HSBC HOLDINGS (00005.HK)$: Invested 0.262 billion HKD to repurchase 2.9952 million shares at a repurchase price of 86.95-87.55 HKD.
$COSCO SHIP HOLD (01919.HK)$: Invested 53.7674 million HKD to repurchase 4.21 million shares at a repurchase price of 12.60-12.86 HKD.
$TIMES ELECTRIC (03898.HK)$: Invested 47.2195 million HKD to repurchase 1.434 million shares at a repurchase price of 32.65-33.2 HKD.
$HBM HOLDINGS-B (02142.HK)$Invested 9.7604 million Hong Kong dollars to repurchase 1.2 million shares, with a repurchase price of 7.96-8.58 Hong Kong dollars.
$SWIRE PACIFIC A (00019.HK)$Invested 12.6659 million Hong Kong dollars to repurchase 0.181 million shares, with a repurchase price of 69.75-70 Hong Kong dollars.
Editor/lambor